ForbesPfizer, Merck and Bristol-Myers Squibb Report Solid ResultsWall Street JournalThree major U.S. drug companies reported solid first-quarter results despite a strong dollar, amid signs that their increasing investment in new cancer drugs will be a key driver of Big Pharma's future growth. Pfizer Inc., Merck & Co. and Bristol-Myers Squibb ...Cancer's six-figure potential blockbusters lift drugmaker salesChicago TribuneCancer-fighting drugs boost pharmaceuticalsSalt Lake TribuneProgress In Cancer Drug Lifts Merck Earnings, Sending Stock HigherForbesStandard-Examinerall 8 news articles »
Pfizer, Merck and Bristol
Rating: 4.5
Diposkan Oleh: Unknown
